1) Eisenhofer G, Keiser H, Friberg P, et al:Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors. J Clin Endocrinol Metab 83:2175-2185,1998
2) Eisenhofer G, Lenders JW, Pacak K:Biochemical diagnosis of pheochromocytoma. Front Horm Res 31:76-106,2004
3) Lenders JW, Pacak K, Walther MM, et al:Biochemical diagnosis of pheochromocytoma:which test is best? JAMA 287:1427-1434,2002
4) Sawka AM, Gafni A, Thabane L, et al:The economic implications of three biochemical screening algorithms for pheochromocytoma. J Clin Endocrinol Metab 89:2859-2866,2004
5) Kudva YC, Sawka AM, Young WF Jr:Clinical review 164:The laboratory diagnosis of adrenal pheochromocytoma:the Mayo Clinic experience. J Clin Endocrinol Metab 88:4533-4539,2003
6) Unger N, Pitt C, Schmidt IL, Petersenn S, et al:Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal mass. Eur J Endocrinol 154:409-417,2006
7) Algeciras-Schimnich A, Preissner CM, Young WF Jr, et al:Plasma chromogranin A or urine fractionated metanephrines follow-up testing improves the diagnostic accuracy of plasma fractionated metanephrines for pheochromocytoma. J Clin Endocrinol Metab 93:91-95,2008